SCHEMBL5221270

SCHEMBL5221270

CCCc1nc(N)sc1C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.44
CYP1A2 P05177 1/20 0.44
HPGD P15428 2/20 0.41
HSD17B10 Q99714 1/20 0.40
FBP1 P09467 1/20 0.39
MAPT P10636 1/20 0.39
GABRP O00591 2/20 0.38
GABRD O14764 2/20 0.38
GABRA1 P14867 2/20 0.38
GABRB1 P18505 2/20 0.38
GABRG2 P18507 2/20 0.38
GABRB3 P28472 2/20 0.38
GABRA5 P31644 2/20 0.38
GABRA3 P34903 2/20 0.38
GABRA2 P47869 2/20 0.38
GABRB2 P47870 2/20 0.38
GABRA4 P48169 2/20 0.38
GABRE P78334 2/20 0.38
GABRA6 Q16445 2/20 0.38
GABRG1 Q8N1C3 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27821918 0.89 GABRP (0.50) ALDH1A1CYP1A2HPGDHSD17B10MAPT
SCHEMBL11338473 0.88 GABRP (0.45) ALDH1A1CYP1A2HPGDHSD17B10MAPT
SCHEMBL1539908 0.87 ALDH1A1 (0.45) ALDH1A1CYP1A2HPGDHSD17B10MAPT
SCHEMBL9369067 0.81 L3MBTL1 (0.40) ALDH1A1HPGDHSD17B10MAPTADORA2A
SCHEMBL9644279 0.81 GPR35 (0.38) ALDH1A1HPGDGABRPGABRDGABRA1
SCHEMBL9643784 0.81 ALDH1A1 (0.36) ALDH1A1HPGDHSP90AA1TSHRAGTR1
SCHEMBL3618179 0.81 ALDH1A1 (0.42) ALDH1A1CYP1A2HPGDHSD17B10MAPT
SCHEMBL31661300 0.81 ALDH1A1 (0.41) ALDH1A1CYP1A2HPGDHSD17B10FBP1
SCHEMBL3100377 0.81 ALDH1A1 (0.47) ALDH1A1CYP1A2HPGDHSD17B10FBP1
SCHEMBL9644174 0.80 ALDH1A1 (0.55) ALDH1A1HPGDMAPTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1525193-B1 ACYLAMINOTHIAZOLE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF SANOFI AVENTIS (FR) 2007-12-26 EP disclosed
EP-1525193-A2 ACYLAMINOTHIAZOLE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF Sanofi-Aventis (FR) 2005-04-27 EP disclosed
WO-2004009565-A2 ACYLAMINOTHIAZOLE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2004-01-29 WO disclosed